-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
FDA finally approves Surfaxin®
- Mar 15, 2012
-
Canada adds heart warnings to Lexapro labels
- May 7, 2012
-
Dole recalls contaminated lettuce
- Jul 2, 2012
-
AstraZeneca blood thinner undergoes trials
- Jul 18, 2012
-
Johnson & Johnson faces new marketing investigations
- Aug 7, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
Tempah colon cancer Nexavar Washington blindness Urban Design Fosamax Avandia Medicaid heart attack breast cancer Drugs medical malpractice HIV test venous thromboembolism Pradaxa femur fractures TVM FDA deep vein thrombosis fentanyl patch SSRI internal bleeding listeria meningitis Travel acetaminophen Nexavar pulmonary embolism
More Dangerous Drug News
Get News Updates By Email
@ConsumerDrugRep Tweets
Archives
- June 2011 (3)
- September 2011 (1)
- October 2011 (3)
- November 2011 (5)
- December 2011 (25)
- January 2012 (8)
- February 2012 (24)
- March 2012 (20)
- April 2012 (6)
- May 2012 (12)
